U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07235046) titled 'A Study of DII235 in Adults With Elevated Lipoprotein(a)' on Nov. 14.
Brief Summary: The main purpose of this study is to determine the safety and efficacy of DII235 in adults with elevated lipoprotein(a).
Study Start Date: Dec. 29
Study Type: INTERVENTIONAL
Condition:
Lipoprotein Disorder
Intervention:
DRUG: DII235
Solution for injection
DRUG: Saline
solution for injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Novartis Pharmaceuticals
Published by HT Digital Content Services with permission from Health Daily Digest....